Kopran Limited

NSE:KOPRAN.NS

335.5 (INR) • At close September 6, 2024
Bedrijfsnaam Kopran Limited
Symbool KOPRAN.NS
Munteenheid INR
Prijs 335.5
Beurswaarde 16,174,656,300
Dividendpercentage 1.2%
52-weken bereik 185.45 - 346.95
Industrie Drug Manufacturers—General
Sector Healthcare
CEO Mr. Surendra Shrikrishna Somani B.Com.
Website https://www.kopran.com

An error occurred while fetching data.

Over Kopran Limited

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant,

Vergelijkbare Aandelen

TTK Healthcare Limited logo

TTK Healthcare Limited

TTKHLTCARE.NS

1,732.7 INR

Nureca Limited logo

Nureca Limited

NURECA.NS

333.8 INR

Sastasundar Ventures Limited logo

Sastasundar Ventures Limited

SASTASUNDR.NS

308.15 INR

Suven Life Sciences Limited logo

Suven Life Sciences Limited

SUVEN.NS

150.57 INR

Shalby Limited logo

Shalby Limited

SHALBY.NS

278.75 INR

Orchid Pharma Limited logo

Orchid Pharma Limited

ORCHPHARMA.NS

1,490.85 INR

Panacea Biotec Limited logo

Panacea Biotec Limited

PANACEABIO.NS

245.92 INR

Neuland Laboratories Limited logo

Neuland Laboratories Limited

NEULANDLAB.NS

12,904.8 INR

Sigachi Industries Limited logo

Sigachi Industries Limited

SIGACHI.NS

56.72 INR

RPG Life Sciences Limited logo

RPG Life Sciences Limited

RPGLIFE.NS

2,319.9 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)